Aortic valve stenosis: from genetics to physiopathology
Aortic valve calcification: The role of lipoprotein (a)
Florian Kronenberg, Innsbruck, Austria
Genetic factors underlying aortic valve calcification
Johanna Kuusisto, Joensuu, Finland
Influence of genes on the susceptibility to atherosclerosis
Novel insight into the genetics of hypetriglyceridemia
Jacqueline Dron, Hamilton, Canada
Polygenic and clinical risk scores and their impact on age of onset and prediction of cardiovascular diseases
Samuli Ripatti, Helsinki, Finland
Mitochondrial dysfunction and vascular health
Cardiovascular risk in survivors of childhood cancer
LC Kremer, Amsterdam, The Netherlands
Role of SIRT3 in mitochondrial dysfuction and cardiovascular diseases
Martin Bennett, United Kingdom
Omega 3 fatty acids and CVD risk: Facts or fantasy?
Benefits of long-chain omega-3 fatty acids : from bench to bedside
Phil Calder, Southampton, United Kingdom
The evolving story of omega-3 trials and reduction of CVD risk
Jane Armitage, Oxford, United Kingdom
Targeting apoCIII or ANGPTL3 to lower TGs
ANGPTLs as a novel targets to reduce CVD risk
Sander Kersten, Wageningen, The Netherlands
Role apo apoC-III in the metabolism of triglyceride rich lipoproteins
Marja-Riitta Taskinen, Helsinki, Finland
Defective efferocytosis and impaired resolution of inflammation
Impaired resolution of inflammation – role of lipid mediators
Magnus Bäck, Stockholm, Sweden
Macrophage immunometabolism in atherosclerosis
Ira Tabas, New York, USA
Extracellular matrix components: guardians of vascular health
Dietary polyphenols and arterial stiffness
Guido R.Y. De Meyer, Antwerp, Belgium
The role of smooth muscle cells in plaque stability
Helle F. Joergensen, Cambridge, United Kingdom
Imaging the vulnerable plaque
Imaging neoatherosclerosis in coronary stent thrombosis
Michael Joner, Munich, Germany
CTA Imaging in the Full Assessment of Coronary Disease Noninvasive Approach to Plaque Anatomy, Ischemia and Risk
Patrick Serruys, The Netherlands
Immunopathological responses elicited by lipoprotein retention in the arterial wall
Apolipoprotein E: a key player in the immunophatological process in atherosclerosis
Christoph Binder, Vienna, Austria
Are mastcells welcomed in the atherosclerotic leasions?
Petri Kovanen, Helsinki, Finland
Association of neoadjuvant chemotherapy with cardiovascular risk
Filippo Crea, Rome, Italy
